Latest Insider Transactions at Age X Therapeutics, Inc. (AGE)
This section provides a real-time view of insider transactions for Age X Therapeutics, Inc. (AGE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AgeX Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AgeX Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,555
-100.0%
|
$10,665
$3.24 P/Share
|
|
Dec 11
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,555
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 10
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
645
-100.0%
|
$1,935
$3.35 P/Share
|
|
Dec 10
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
645
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 09
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
600
-100.0%
|
$1,800
$3.31 P/Share
|
|
Dec 09
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 03
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$15,000
$3.52 P/Share
|
|
Dec 03
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 02
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$4,500
$3.91 P/Share
|
|
Dec 02
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 25
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,965
-50.0%
|
$17,895
$3.9 P/Share
|
|
Nov 25
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,965
+33.33%
|
$0
$0.06 P/Share
|
|
Nov 24
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
535
-100.0%
|
$1,605
$3.94 P/Share
|
|
Nov 24
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
535
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 18
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$19,500
$3.75 P/Share
|
|
Nov 18
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 10
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$26,000
$4.1 P/Share
|
|
Nov 10
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 05
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,398
-100.0%
|
$13,592
$4.24 P/Share
|
|
Nov 05
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,398
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 04
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,102
-100.0%
|
$12,408
$4.4 P/Share
|
|
Nov 04
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,102
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 28
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,551
-100.0%
|
$22,204
$4.96 P/Share
|
|
Oct 28
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,551
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 27
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
949
-100.0%
|
$4,745
$5.19 P/Share
|
|
Oct 27
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
949
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 20
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$26,000
$4.97 P/Share
|
|
Oct 20
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 13
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,326
-100.0%
|
$21,630
$5.2 P/Share
|
|
Oct 13
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,326
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 26
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
45,632
-100.0%
|
$319,424
$7.01 P/Share
|
|
Aug 26
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,632
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 25
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,042
-100.0%
|
$10,210
$5.65 P/Share
|
|
Aug 25
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,042
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 20
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,077
-100.0%
|
$10,385
$5.1 P/Share
|
|
Aug 20
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,077
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 18
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,227
-100.0%
|
$11,135
$5.25 P/Share
|
|
Aug 18
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,227
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 12
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-100.0%
|
$27,500
$5.25 P/Share
|
|
Aug 12
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 04
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-100.0%
|
$27,500
$5.17 P/Share
|
|
Aug 04
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 29
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,196
-100.0%
|
$25,176
$6.5 P/Share
|
|
Jul 29
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,196
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 28
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$32,500
$5.89 P/Share
|
|
Jul 28
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 21
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$32,500
$5.34 P/Share
|
|
Jul 21
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 14
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$32,500
$5.01 P/Share
|
|
Jul 14
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|